Literature DB >> 31718748

The GOLD Summit on chronic obstructive pulmonary disease in low- and middle-income countries.

D M G Halpin1, B R Celli2, G J Criner3, P Frith4, M V López Varela5, S Salvi6, C F Vogelmeier7, R Chen8, K Mortimer9, M Montes de Oca10, Z Aisanov11, D Obaseki12, R Decker13, A Agusti14.   

Abstract

Chronic obstructive pulmonary disease (COPD) is one of the top three causes of death worldwide, but governments and non-governmental organisations have not given its prevention and treatment the priority it requires. This is particularly true in low- and middle-income countries, where most of the people suffering from this disease live. The United Nations (UN) has targeted a reduction of premature deaths from non-communicable diseases (NCDs) by a third by 2030; however, a coordinated UN/World Health Organization (WHO) strategy to address the burden of COPD (one of the most important NCDs) is still lacking. To explore the extent of the problem and inform the development of policies to improve the situation, the Board of Directors of the Global Initiative for Chronic Obstructive Lung Disease (GOLD) held a 1-day Summit. The key themes that emerged were the need to ensure accurate data on prevalence, raise awareness of the disease among the public, healthcare professionals and governments, including the fact that COPD aetiology goes beyond smoking (and other inhaled pollutants) and includes poor lung development in early life, and ensure that spirometry and both pharmacological and non-pharmacological therapies are available and affordable. Here, we present the actions that must be taken to address the impact of COPD. We believe that the WHO is particularly well-positioned to co-ordinate an attack on COPD, and GOLD will do all it can to help and rally support.

Entities:  

Mesh:

Year:  2019        PMID: 31718748     DOI: 10.5588/ijtld.19.0397

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN: 1027-3719            Impact factor:   2.373


  18 in total

1.  A Meta-Analysis on the Efficacy and Safety of Bacterial Lysates in Chronic Obstructive Pulmonary Disease.

Authors:  Yongkang Huang; Yongjian Pei; Yajuan Qian; Zhen Yao; Chen Chen; Juan Du; Minhua Shi; Tong Zhou
Journal:  Front Med (Lausanne)       Date:  2022-06-09

2.  Proteome analysis of urinary biomarkers in a cigarette smoke-induced COPD rat model.

Authors:  Weiwei Qin; He Huang; Yuting Dai; Wei Han; Youhe Gao
Journal:  Respir Res       Date:  2022-06-15

3.  Relationship between risk, cumulative burden of exacerbations and mortality in patients with COPD: modelling analysis using data from the ETHOS study.

Authors:  Kirsty Rhodes; Martin Jenkins; Enrico de Nigris; Magnus Aurivillius; Mario Ouwens
Journal:  BMC Med Res Methodol       Date:  2022-05-25       Impact factor: 4.612

4.  Low-dose theophylline in addition to ICS therapy in COPD patients: A systematic review and meta-analysis.

Authors:  Tiankui Shuai; Chuchu Zhang; Meng Zhang; Yalei Wang; Huaiyu Xiong; Qiangru Huang; Jian Liu
Journal:  PLoS One       Date:  2021-05-24       Impact factor: 3.240

5.  Clinical features of Japanese patients with exacerbations of chronic obstructive pulmonary disease.

Authors:  Hiroki Tashiro; Yuki Kurihara; Koichiro Takahashi; Hironori Sadamatsu; Tetsuro Haraguchi; Ryo Tajiri; Ayako Takamori; Shinya Kimura; Naoko Sueoka-Aragane
Journal:  BMC Pulm Med       Date:  2020-12-07       Impact factor: 3.317

6.  Identification of the Key Immune-Related Genes in Chronic Obstructive Pulmonary Disease Based on Immune Infiltration Analysis.

Authors:  Hongqiong Meng; Qionghua Long; Ruiping Wang; Xian Zhou; Huipeng Su; Tingting Wang; Ya Li
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2022-01-04

Review 7.  COPD in Firefighters: A Specific Event-Related Condition Rather than a Common Occupational Respiratory Disorder.

Authors:  Armand-Gabriel Rajnoveanu; Ruxandra-Mioara Rajnoveanu; Nicoleta Stefania Motoc; Paraschiva Postolache; Gabriel Gusetu; Milena Adina Man
Journal:  Medicina (Kaunas)       Date:  2022-02-05       Impact factor: 2.430

8.  Chronic obstructive pulmonary disease in sub-Saharan Africa.

Authors:  B I Awokola; G A Amusa; C P Jewell; G Okello; M Stobrink; L J Finney; N Mohammed; A Erhart; K J Mortimer
Journal:  Int J Tuberc Lung Dis       Date:  2022-03-01       Impact factor: 3.427

9.  Prescription is not enough: the importance of adherence to pharmacological treatment of COPD.

Authors:  Eanes Delgado Barros Pereira; Antonio George de Matos Cavalcante
Journal:  J Bras Pneumol       Date:  2022-03-14       Impact factor: 2.624

10.  Network Meta-Analysis of the Effects of Different Types of Traditional Chinese Exercises on Pulmonary Function, Endurance Capacity and Quality of Life in Patients With COPD.

Authors:  Lingling Li; Hailiang Huang; Jiao Song; Ying Yu; Yuqi Jia; Yajie Wang; Xiaowen Dang; Lei Huang; Xinyue Liu
Journal:  Front Med (Lausanne)       Date:  2022-02-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.